A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study.
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Influence of a PSychological Intensive Support Program for Lung Cancer Patients ON Post-operative Outcomes.
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
- Status
- RECRUITING
- Phase
- NA
Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
- Status
- RECRUITING
- Phase
- PHASE2
Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
HC010 in First-line PD-L1 Positive Advanced NSCLC Patients
- Status
- RECRUITING
- Phase
- PHASE2
Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
PET/CT for Trop2 ADC Response Evaluation NSCLC
- Status
- RECRUITING
- Phase
- N/A
The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases
- Status
- RECRUITING
- Phase
- PHASE4
Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2